% Vaccination coverage (with 95% CI) | Rate ratios for non-uptake among children with intellectual disability (reference group = other children) | ||||
---|---|---|---|---|---|
Children with intellectual disabilities | Other children | Unadjusted | Model 1 (SEP) | Model 2 (SEP + other factors) | |
Age 9 months | (n = 551) | (n = 17,986) | |||
Fully or partially vaccinated | 97.6% (95.7–98.6) | 98.7% (98.5–99.0) | 1.93 (1.09–3.43)* | 1.33 (0.69–2.57) | 1.33 (0.71–2.53) |
Fully vaccinated | 89.5% (86.2–92.1) | 95.2% (94.8–95.7) | 2.03 (1.14–3.60)* | 1.38 (0.71–2.637) | 1.38 (0.73–2.63) |
Partially vaccinated | 8.0% (5.8–11.0) | 3.5% (3.2–3.9) | 0.88 (0.53–1.47) | 0.90 (0.50–1.63) | 0.96 (0.54–1.70) |
No vaccinations | 2.4% (1.4–4.3) | 1.3% (1.1–1.6) | |||
Age 3 years | (n = 521) | (n = 14,261) | |||
Polio complete | 97.3% (95.1–98.6) | 98.8% (98.6–99.0) | 2.27 (1.20–4.29)* | 2.22 (1.16–4.23)* | 2.18 (1.13–4.19)* |
Diptheria complete | 98.2% (96.3–99.1) | 98.8% (98.6–99.1) | 1.59 (0.78–3.23) | 1.48 (0.70–3.13) | 1.47 (0.70–3.15) |
Tetanus complete | 97.7% (95.8–98.8) | 98.9% (98.6–99.1) | 2.02 (1.07–3.82)* | 1.89 (0.97–3.66) | 1.90 (0.97–3.71) |
Pertussis complete | 96.4% (93.8–98.0) | 98.4% (98.1–98.7) | 2.23 (1.27–3.92)** | 2.07 (1.16–3.70)* | 2.12 (1.19–3.79)* |
Hib complete | 96.5% (93.9–98.0) | 98.2% (97.8–98.5) | 1.95 (1.10–3.45)* | 1.78 (0.98–3.23) | 1.78 (0.98–3.23) |
Meningitis complete | 96.7% (94.2–98.1) | 98.1% (97.7–98.4) | 1.73 (0.98–3.07) | 1.59 (0.87–2.92) | 1.62 (0.87–3.01) |
MMR | 91.6% (88.1–94.2) | 93.9% (93.2–94.6) | 1.38 (0.96–1.09) | 1.24 (0.85–1.80) | 1.18 (0.81–1.72) |
Fully or partially vaccinated | 98.1% (96.2–99.0) | 99.1% (98.8–99.3) | 2.06 (1.01–4.22)* | 1.77 (0.82–3.79) | 1.78 (0.83–3.81) |
Fully vaccinated | 84.9% (80.8–88.3) | 90.1% (89.2–90.9) | 2.16 (1.06–4.43)* | 1.82 (0.85–3.92) | 1.83 (0.86–3.91) |
Partially vaccinated | 13.2% (10.1–17.1) | 9.0% (8.2–9.7) | 1.35 (0.70–2.63) | 1.35 (0.66–2.77) | 1.35 (0.66–2.75) |
No vaccinations | 1.9% (1.0–3.8) | 0.9% (0.7–1.2) | |||
Age 5 years | (n = 524) | (n = 14,365) | |||
Booster DTP | 94.5% (91.9–96.3) | 96.0% (95.5–96.4) | 1.38 (0.92–2.06) | 1.19 (0.79–1.79) | 1.17 (0.77–1.77) |
All 3 doses combined DTP | 98.7% (97.0–99.5) | 99.2% (98.9–99.4) | 1.56 (0.64–3.81) | 1.43 (0.54–3.77) | 1.36 (0.51–3.63) |
Booster polio | 94.9% (92.4–96.7) | 95.2% (94.6–95.7) | 1.06 (0.69–1.61) | 0.99 (0.64–1.94) | 0.98 (0.63–1.54) |
All three doses Polio | 98.7% (97.1–99.5) | 99.2% (99.0–99.4) | 1.61 (0.68–3.79) | 1.57 (0.62–4.01) | 1.51 (0.60–3.84) |
All 3 doses Meningitis C | 97.8% (95.5–98.9) | 98.4% (98.1–98.7) | 1.40 (0.70–2.82) | 1.33 (0.63–2.79) | 1.32 (0.63–2.74) |
MMR | 96.9% (95.0–98.1) | 96.8% (96.2–97.2) | 0.96 (0.58–1.58) | 1.07 (0.64–1.79) | 1.01 (0.60–1.70) |
Fully or partially vaccinated | 99.1% (97.4–99.7) | 99.5% (99.3–99.6) | 1.88 (0.66–5.39) | 2.01 (0.61–6.59) | 1.93 (0.59–6.35) |
Fully vaccinated | 87.4% (83.9–90.2) | 89.3% (88.4–90.1) | 1.91 (0.67–5.49) | 1.97 (0.60–6.44) | 1.88 (0.58–6.13) |
Partially vaccinated | 11.7% (9.1–14.9) | 10.2% (9.5–11.1) | 1.60 (0.59–4.36) | 2.18 (0.69–6.88) | 2.20 (0.72–6.77) |
No vaccinations | 1.0% (0.3–2.7) | 0.5% (0.4–0.7) | |||
Age 14 years | (n = 149) | (n = 4938) | |||
HPV (girls only) | 87.4% (77.9–93.2) | 93.1% (92.1–94.0) | 1.83 (0.99–3.37) | 1.59 (0.83–3.03) | 1.52 (0.78–2.98) |